152 related articles for article (PubMed ID: 22126559)
1. Survival and prognostic factors comparing stage IB 1 versus stage IB 2 cervical cancer treated with primary radical hysterectomy.
Srisomboon J; Kietpeerakool C; Suprasert P; Manopanya M; Siriaree S; Charoenkwan K; Cheewakriangkrai C; Sae-Teng C
Asian Pac J Cancer Prev; 2011; 12(7):1753-6. PubMed ID: 22126559
[TBL] [Abstract][Full Text] [Related]
2. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
Lin HH; Cheng WF; Chan KW; Chang DY; Chen CK; Huang SC
Obstet Gynecol; 1996 Aug; 88(2):274-9. PubMed ID: 8692515
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors associated with recurrence in stage IB cervical carcinoma after radical hysterectomy and pelvic lymphadenectomy.
Wilailak S; Tangtrakul S; Srisupundit S; Bullangpoti S; Linasmita V; Bhamarapravati Y
J Med Assoc Thai; 1993 Jan; 76 Suppl 1():74-7. PubMed ID: 8113662
[TBL] [Abstract][Full Text] [Related]
5. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ
Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
[TBL] [Abstract][Full Text] [Related]
6. Stage IB and IIA cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy.
Schorge JO; Molpus KL; Koelliker D; Nikrui N; Goodman A; Fuller AF
Gynecol Oncol; 1997 Jul; 66(1):31-5. PubMed ID: 9234917
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors of early stage cervical cancer treated by radical hysterectomy.
Sevin BU; Nadji M; Lampe B; Lu Y; Hilsenbeck S; Koechli OR; Averette HE
Cancer; 1995 Nov; 76(10 Suppl):1978-86. PubMed ID: 8634988
[TBL] [Abstract][Full Text] [Related]
8. [The value of adjuvant irradiation in lymphatic vessel invasion in patients with a cervical carcinoma in histopathological stage Ib and with negative lymph nodes].
Vavra N; Sevelda P; Seifert M; Timar J; Kudielka I; Kucera H
Strahlenther Onkol; 1992 Sep; 168(9):524-7. PubMed ID: 1411926
[TBL] [Abstract][Full Text] [Related]
9. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy.
Harrison TA; Sevin BU; Koechli O; Nguyen HN; Averette HE; Penalver M; Donato DM; Nadji M
Gynecol Oncol; 1993 Sep; 50(3):310-5. PubMed ID: 8406193
[TBL] [Abstract][Full Text] [Related]
10. Implications of a failed prospective trial of adjuvant therapy after radical hysterectomy for stage Ib-IIa cervical carcinoma with pelvic node metastases.
Lai CH; Tang SG; Chang TC; Tseng CJ; Chou HH; Huang KG; Hsueh S; Hong JH; Huang SL; Lin JD; Soong YK
Changgeng Yi Xue Za Zhi; 1998 Sep; 21(3):291-9. PubMed ID: 9849010
[TBL] [Abstract][Full Text] [Related]
11. Blood transfusion and the risk of recurrence in stage IB cervical cancer.
Morris PC; Haugen J; Tomjack J; Anderson B; Buller RE
Gynecol Oncol; 1995 Jun; 57(3):401-6. PubMed ID: 7774845
[TBL] [Abstract][Full Text] [Related]
12. Radical hysterectomy in the treatment of cervical cancer.
Benedet JL; Turko M; Boyes DA; Nickerson KG; Bienkowska BT
Am J Obstet Gynecol; 1980 May; 137(2):254-62. PubMed ID: 7377245
[TBL] [Abstract][Full Text] [Related]
13. Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage IB cervical cancer patients.
Alvarez RD; Potter ME; Soong SJ; Gay FL; Hatch KD; Partridge EE; Shingleton HM
Gynecol Oncol; 1991 Nov; 43(2):108-12. PubMed ID: 1743550
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage Ib-IIa cervical cancer patients with pelvic lymph node metastases.
Tattersall MH; Ramirez C; Coppleson M
Gynecol Oncol; 1992 Aug; 46(2):176-81. PubMed ID: 1500019
[TBL] [Abstract][Full Text] [Related]
15. Recurrence and survival analyses of 1,115 cervical cancer patients treated with radical hysterectomy.
Yuan C; Wang P; Lai C; Tsu E; Yen M; Ng H
Gynecol Obstet Invest; 1999; 47(2):127-32. PubMed ID: 9949284
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of parametrial extension in patients with cervical carcinoma Stages IB, IIA, and IIB. A study of 628 cases treated by radical hysterectomy and lymphadenectomy with or without postoperative irradiation.
Inoue T; Okumura M
Cancer; 1984 Oct; 54(8):1714-9. PubMed ID: 6478409
[TBL] [Abstract][Full Text] [Related]
17. Radical hysterectomy versus radiation therapy for stage IB squamous cell cancer of the cervix.
Hopkins MP; Morley GW
Cancer; 1991 Jul; 68(2):272-7. PubMed ID: 2070325
[TBL] [Abstract][Full Text] [Related]
18. Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix.
Alvarez RD; Soong SJ; Kinney WK; Reid GC; Schray MF; Podratz KC; Morley GW; Shingleton HM
Gynecol Oncol; 1989 Nov; 35(2):130-5. PubMed ID: 2807001
[TBL] [Abstract][Full Text] [Related]
19. Survival impact of additional chemotherapy after adjuvant concurrent chemoradiation in patients with early cervical cancer who underwent radical hysterectomy.
Kim SI; Kim JY; Wee CW; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Park NH; Song YS; Kim TH
BMC Cancer; 2021 Nov; 21(1):1260. PubMed ID: 34809599
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB.
Inoue T; Morita K
Cancer; 1990 May; 65(9):1923-7. PubMed ID: 2372764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
